COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(8 sites)
Canada
Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia QEII Health Science Centre, Halifax, Nova Scotia Kingston General Hospital, Kingston, Ontario The Ottawa Hospital - General Campus, Ottawa, Ontario University Ottawa Heart Institute, Ottawa, Ontario CISSS de l'Outaouais, Gatineau, Quebec CHU de Quebec - Université Laval, Laval, Quebec Ciusss Nim, Montreal, Quebec Age range
18 Years and older
Last updated November 2025